 The Coalition for Epidemic Preparedness Innovations CEPI and VBI Vaccines Inc NASDAQ: VBIV entered into a partnership for the development of VBIs enveloped virus-like particle eVLP vaccine candidates against SARS-CoV-2 variants, including the South African B.1.351 variant, also known as 501Y.V2. CEPI is an international coalition set up to prepare for future infectious disease threats. 